The synthesis of
trans-[RuCl(NO)(cyclam)]
2+ (cyclam = 1,4,8,11-tetraazacyclotetradecane) can be accomplishedby either the addition of cyclam to K
2[RuCl
5NO] or by the addition of NO to
trans-[RuCl(CF
3SO
3)(cyclam)](CF
3SO
3). Crystals of
trans-[RuCl(NO)(cyclam)](ClO
4)
2 form in the monoclinic space group
P2
1/
c, with unit cellparameters of
a = 7.66500(2) Å,
b = 24.7244(1) Å,
c = 16.2871(2) Å,
![](/images/gifchars/beta2.gif)
= 95.2550(10)
![](/images/entities/deg.gif)
, and
Z = 4. One of thetwo independent molecules in the unit cell lies disordered on a center of symmetry. For the ion in the generalposition, the Ru-N and N-O bond distances and the [Ru-N-O]
3+ bond angle are 1.747(4) Å, 1.128(5) Å,178.0(4)
![](/images/entities/deg.gif)
, respectively. In both ions, cyclam adopts the (R,R,S,S) configuration, which is also consistent with 2DCOSY
1H NMR studies in aqueous solution. Reduction (
E![](/images/entities/deg.gif)
= -0.1 V) results in the rapid loss of Cl
- by first-order kinetics with
k = 1.5 s
-1 and the slower loss of NO (
k = 6.10 × 10
-4 s
-1,
H![](/images/entities/thermod.gif)
= 15.3 kcal mol
-1,
S![](/images/entities/thermod.gif)
= -21.8 cal mol
-1 K
-1). The slow release of NO following reduction causes
trans-[RuCl(NO)(cyclam)]
2+ to bea promising controlled-release NO prodrug for vasodilation and other purposes. Unlike the related complex
trans-[Ru(NO)(NH
3)
4(P(OEt)
3)](PF
6)
2,
trans-[RuCl(NO)(cyclam)]Cl
2 is inactive in modulating
evoked potentials recordedfrom mice hippocampal slices probably because of the slower dissociation of NO following reduction.